These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38228745)

  • 1. Peripheral neurotrophin levels during controlled crack/cocaine abstinence: a systematic review and meta-analysis.
    Morelos-Santana E; Islas-Preciado D; Alcalá-Lozano R; González-Olvera J; Estrada-Camarena E
    Sci Rep; 2024 Jan; 14(1):1410. PubMed ID: 38228745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotrophic factors in women with crack cocaine dependence during early abstinence: the role of early life stress.
    Viola TW; Tractenberg SG; Levandowski ML; Pezzi JC; Bauer ME; Teixeira AL; Grassi-Oliveira R
    J Psychiatry Neurosci; 2014 May; 39(3):206-14. PubMed ID: 24331739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in brain-derived neurotrophic factor expression in early crack cocaine withdrawal.
    von Diemen L; Kapczinski F; Sordi AO; de Magalhães Narvaez JC; Guimarães LS; Kessler FH; Pfaffenseller B; de Aguiar BW; de Moura Gubert C; Pechansky F
    Int J Neuropsychopharmacol; 2014 Jan; 17(1):33-40. PubMed ID: 24067327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum BDNF levels increase during early drug withdrawal in alcohol and crack cocaine addiction.
    Ornell F; Scherer JN; Schuch JB; Sordi AO; Halpern SC; Rebelatto FP; Bristot G; Kapczinski F; Roglio VS; Pechansky F; Kessler FHP; von Diemen L
    Alcohol; 2023 Sep; 111():1-7. PubMed ID: 37037287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in brain-derived neurotrophic factor (BDNF) during abstinence could be associated with relapse in cocaine-dependent patients.
    Corominas-Roso M; Roncero C; Daigre C; Grau-Lopez L; Ros-Cucurull E; Rodríguez-Cintas L; Sanchez-Mora C; Lopez MV; Ribases M; Casas M
    Psychiatry Res; 2015 Feb; 225(3):309-14. PubMed ID: 25592977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress and BDNF as possible markers for the severity of crack cocaine use in early withdrawal.
    Sordi AO; Pechansky F; Kessler FH; Kapczinski F; Pfaffenseller B; Gubert C; de Aguiar BW; de Magalhães Narvaez JC; Ornell F; von Diemen L
    Psychopharmacology (Berl); 2014 Oct; 231(20):4031-9. PubMed ID: 24676990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of oxidative stress and brain-derived neurotrophic factor levels related to crack-use detoxification.
    Hirsch GE; Jaskulski M; Hamerski HM; Porto FG; da Silva B; Aita CAM; Kroker K; de Bem Silveira G; Silveira PCL; Santos GT; Klafke JZ; Viecili PRN
    Neurosci Lett; 2018 Mar; 670():62-68. PubMed ID: 29374540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-Derived Neurotrophic Factor and Delayed Verbal Recall in Crack/Cocaine Dependents.
    Viola TW; Tractenberg SG; Kluwe-Schiavon B; Levandowski ML; Sanvicente-Vieira B; Wearick-Silva LE; de Azeredo LA; Teixeira AL; Grassi-Oliveira R
    Eur Addict Res; 2015; 21(5):273-8. PubMed ID: 26022436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attention and memory deficits in crack-cocaine users persist over four weeks of abstinence.
    Almeida PP; de Araujo Filho GM; Malta SM; Laranjeira RR; Marques ACRP; Bressan RA; Lacerda ALT
    J Subst Abuse Treat; 2017 Oct; 81():73-78. PubMed ID: 28847458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-derived neurotrophic factor serum levels in cocaine-dependent patients during early abstinence.
    Corominas-Roso M; Roncero C; Eiroa-Orosa FJ; Gonzalvo B; Grau-Lopez L; Ribases M; Rodriguez-Cintas L; Sánchez-Mora C; Ramos-Quiroga JA; Casas M
    Eur Neuropsychopharmacol; 2013 Sep; 23(9):1078-84. PubMed ID: 23021567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of crack cocaine addiction and stress-related genes on peripheral BDNF levels.
    Rovaris DL; Schuch JB; Grassi-Oliveira R; Sanvicente-Vieira B; da Silva BS; Walss-Bass C; Müller D; Stolf AR; von Diemen L; Ceresér KMM; Pianca TG; Szobot CM; Kessler FHP; Roman T; Bau CHD
    J Psychiatr Res; 2017 Jul; 90():78-85. PubMed ID: 28237884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in biomarkers of crack-cocaine adolescent users before/after abstinence.
    Pianca TG; Rosa RL; Ceresér KMM; de Aguiar BW; de Abrahão RC; Lazzari PM; Kapczinski F; Pechansky F; Rohde LA; Szobot CM
    Drug Alcohol Depend; 2017 Aug; 177():207-213. PubMed ID: 28618284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High levels of brain-derived neurotrophic factor are associated with treatment adherence among crack-cocaine users.
    Scherer JN; Schuch S; Ornell F; Sordi AO; Bristot G; Pfaffenseller B; Kapczinski F; Kessler FHP; Fumagalli F; Pechansky F; von Diemen L
    Neurosci Lett; 2016 Sep; 630():169-175. PubMed ID: 27473943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of childhood trauma on BDNF and TBARS during crack-cocaine withdrawal.
    Sordi AO; von Diemen L; Kessler FH; Schuch S; Ornell F; Kapczinski F; Pfaffenseller B; Gubert C; Wollenhaupt-Aguiar B; Salum GA; Pechansky F
    Braz J Psychiatry; 2020 Apr; 42(2):214-217. PubMed ID: 31826099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive functions of subjects with cocaine and crack dependency disorder during early abstinence.
    Alonso-Matias L; Reyes-Zamorano E; Gonzalez-Olvera JJ
    Rev Neurol; 2019 Apr; 68(7):271-280. PubMed ID: 30906976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid receptor gene modulates severity of depression in women with crack cocaine addiction.
    Rovaris DL; Aroche AP; da Silva BS; Kappel DB; Pezzi JC; Levandowski ML; Hess ARB; Schuch JB; de Almeida RMM; Grassi-Oliveira R; Bau CHD
    Eur Neuropsychopharmacol; 2016 Sep; 26(9):1438-1447. PubMed ID: 27397864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac and mood-related changes during short-term abstinence from crack cocaine: the identification of possible withdrawal phenomena.
    Kajdasz DK; Moore JW; Donepudi H; Cochrane CE; Malcolm RJ
    Am J Drug Alcohol Abuse; 1999 Nov; 25(4):629-37. PubMed ID: 10548439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of inhibitory control in crack and/or cocaine users: a systematic review.
    Czermainski FR; Willhelm AR; Santos ÁZ; Pachado MP; de Almeida RMM
    Trends Psychiatry Psychother; 2017; 39(3):216-225. PubMed ID: 28813109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contingency management targeting abstinence is effective in reducing depressive and anxiety symptoms among crack cocaine-dependent individuals.
    Miguel AQC; Madruga CS; Cogo-Moreira H; Yamauchi R; Simões V; Ribeiro A; da Silva CJ; Fruci A; McDonell M; McPherson S; Roll JM; Laranjeira RR
    Exp Clin Psychopharmacol; 2017 Dec; 25(6):466-472. PubMed ID: 29251975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.